Recent Posts
- New collaboration will use AI tools to find ALS treatment targets
- Phase 3 trial of masitinib can now launch in US, some EU countries
- What we’ve learned about ALS progression over 15 years
- FDA clears troculeucel for expanded access program
- First Hoffman award winners to expand multidisciplinary ALS care